Skip to main content
SpringerLink
Log in
Book cover

The Right Heart pp 209–221Cite as

Left Heart Failure

  • Chapter
  • First Online:

  • 1284 Accesses

Abstract

Heart failure (HF) has been considered for many years a disease of the left ventricle. Much research has been done on left ventricular (LV) function, the determinants of its failure, and the consequent effects on morbidity and mortality of HF patients, whereas less attention has been paid to the right ventricle (RV) and its failure. Things have changed in recent years. Nowadays it has become clear to clinicians and to researchers that the right ventricle plays a critical role in patients with left heart disease.

This review summarizes available data on prevalence, clinical correlates, prognostic relevance, pathophysiologic determinants and treatment of RV failure in the context of Left Heart failure (HF). The focus is on four clinical conditions: chronic HF with reduced ejection fraction of the left ventricle, HF with preserved ejection fraction of the left ventricle, acute decompensated HF and end-stage HF patients undergoing implantation of a LV assist device.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847.

    Article  PubMed  Google Scholar 

  2. Franciosa JA, Baker BJ, Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J. 1985;110:807.

    Article  CAS  PubMed  Google Scholar 

  3. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol. 1999;34:1802–6.

    Article  CAS  PubMed  Google Scholar 

  4. Baker BJ, Wilen MM, Boyd CM, Dinh H, Franciosa JA. Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol. 1984;54:596–9.

    Article  CAS  PubMed  Google Scholar 

  5. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 1995;25:1143–53.

    Article  PubMed  Google Scholar 

  6. de Groote P, Millaire A, Foucher-Hossein C, Nugue O, Marchandise X, Ducloux G, Lablanche JM. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol. 1998;32:948–54.

    Article  PubMed  Google Scholar 

  7. Zornoff LA, Skali H, Pfeffer MA, St John Sutton M, Rouleau JL, Lamas GA, Plappert T, Rouleau JR, Moyé LA, Lewis SJ, Braunwald E, Solomon SD, SAVE Investigators. Right ventricle dysfunction and risk of heart failure mortality after myocardial infarction. J Am Coll Cardiol. 2002;39:1450–5.

    Article  PubMed  Google Scholar 

  8. Karatasakis GT, Karagounis LA, Kalyvas PA, Manginas A, Athanassopoulos GD, Aggelakas SA, Cokkinos DV. Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure. Am J Cardiol. 1998;82:329–34.

    Article  CAS  PubMed  Google Scholar 

  9. Ghio S, Recusani F, Klersy C, Sebastiani R, Laudisa ML, Campana C, Gavazzi A, Tavazzi L. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 2000;85:837–42.

    Article  CAS  PubMed  Google Scholar 

  10. Dini FL, Demmer RT, Simioniuc A, Morrone D, Donati F, Guarini G, Orsini E, Caravelli P, Marzilli M, Colombo PC. Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. Eur J Heart Fail. 2012;14:287–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Damy T, Kallvikbacka-Bennett A, Goode K, Khaleva O, Lewinter C, Hobkirk J, Nikitin NP, Dubois-Randé JL, Hittinger L, Clark AL, Cleland JG. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail. 2012;18:216–25.

    Article  PubMed  Google Scholar 

  12. Kjaergaard J, Akkan D, Iversen KK, Kober L, Torp-Pedersen C, Hassager C. Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure. Eur J Heart Fail. 2007;9:610–6.

    Article  PubMed  Google Scholar 

  13. Lucreziotti S, Gavazzi A, Scelsi L, Inserra C, Klersy C, Campana C, Ghio S, Vanoli E, Tavazzi L. Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. Am Heart J. 2000;139:1088–95.

    Article  CAS  PubMed  Google Scholar 

  14. Mariano-Goulart D, Eberlé M-C, Boudousq V, et al. Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure. Eur J Heart Fail. 2003;5:481–8.

    Article  CAS  PubMed  Google Scholar 

  15. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183–8.

    Article  CAS  PubMed  Google Scholar 

  16. Temporelli PL, Scapellato F, Eleuteri E, Imparato A, Giannuzzi P. Doppler echocardiography in advanced systolic heart failure: a noninvasive alternative to Swan-Ganz catheter. Circ Heart Fail. 2010;3:387–94.

    Article  PubMed  Google Scholar 

  17. Ghio S, Temporelli PL, Klersy C, Simioniuc A, Girardi B, Scelsi L, Rossi A, Cicoira M, Tarro Genta F, Dini FL. Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. Eur J Heart Fail. 2013;15:408–14.

    Article  PubMed  Google Scholar 

  18. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Circulation. 2006;114:1883–91.

    Article  PubMed  Google Scholar 

  19. Morrison D, Goldman S, Wright AL, Henry R, Sorenson S, Caldwell J, Ritchie J. The effect of pulmonary hypertension on systolic function of the right ventricle. Chest. 1983;84:250–7.

    Article  CAS  PubMed  Google Scholar 

  20. Vatta M, Stetson SJ, Jimenez S, Entman ML, Noon GP, Bowles NE, Towbin JA, Torre-Amione G. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol. 2004;43:811–7.

    Article  CAS  PubMed  Google Scholar 

  21. Hirose K, Shu NH, Reed JE, Rumberger JA. Right ventricular dilatation and remodelling the first year after an initial transmural wall left ventricular myocardial infarction. Am J Cardiol. 1993;72:1126–30.

    Article  CAS  PubMed  Google Scholar 

  22. Juillière Y, Buffet P, Marie PY, Berder V, Danchin N, Cherrier F. Comparison of right ventricular systolic function in idiopathic dilated cardiomyopathy and healed anterior wall myocardial infarction associated with atherosclerotic coronary artery disease. Am J Cardiol. 1994;73:588–90.

    Article  PubMed  Google Scholar 

  23. Elliott P, O’Mahony C, Syrris P, Evans A, Rivera Sorensen C, Sheppard MN, Carr-White G, Pantazis A, McKenna WJ. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ Cardiovasc Genet. 2010;3:314e22.

    Article  Google Scholar 

  24. Insolia R, Zuccolo E, Ghio S, Mbele M, Fish M, Shaboodien G, Sliwa K, Kotta MC, Torchio M, Scelsi L, Raineri C, Lucibello S, Crotti L, Mayosi BM, Schwartz PJ (2013) Prevalence of mutations in plakophilin-2 and desmoplakin genes in Caucasians and in black African patients with dilated cardiomyopathy (Abstract). Atti della Società Italian di Genetica Umana, XVI Congresso Nazionale, Roma 25–28 Sept 2013.

    Google Scholar 

  25. Nagendran J, Gurtu V, Fu DZ, Dyck JR, Haromy A, Ross DB, Rebeyka IM, Michelakis ED. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. J Thorac Cardiovasc Surg. 2008;136:168–78, 78 e1–3.

    Article  PubMed  Google Scholar 

  26. Gurwitz JH, Magid DJ, Smith DH, Goldberg RJ, McManus DD, Allen LA, Saczynski JS, Thorp ML, Hsu G, Sung SH, Go AS. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013;126:393–400.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–9.

    Article  CAS  PubMed  Google Scholar 

  28. Liao L, Jollis JG, Anstrom KJ, Whellan DJ, Kitzman DW, Aurigemma GP, Mark DB, Schulman KA, Gottdiener JS. Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med. 2006;166:112–8.

    Article  PubMed  Google Scholar 

  29. Lam CSP, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009;53:1119–26.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Bursi F, McNallan SM, Redfield MM, Nkomo VT, Lam CS, Weston SA, Jiang R, Roger VL. Pulmonary pressures and death in heart failure. A community study. J Am Coll Cardiol. 2012;59:222–31.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Puwanant S, Priester TC, Mookadam F, Bruce CJ, Redfield MM, Chandrasekaran K. Right ventricular function in patients with preserved and reduced ejection fraction heart failure. Eur J Echocardiogr. 2009;10:733–7.

    Article  PubMed  Google Scholar 

  32. Agarwal R, Shah SJ, Foreman AJ, Glassner C, Bartolome SD, Safdar Z, Coslet SL, Anderson AS, Gomberg-Maitland M. Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction. J Heart Lung Transplant. 2012;31:467–77.

    Article  PubMed  Google Scholar 

  33. Berkowitz R, Alhaj E, Manchikalapudi RB, Satya K, Dadfarmay S, Zakir R. Determinants of right ventricular failure in patients admitted with acute left heart failure. Congest Heart Fail. 2010;16:243–8.

    Article  PubMed  Google Scholar 

  34. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456–67.

    Article  CAS  PubMed  Google Scholar 

  35. Hernandez AF, Hammill BG, O’Connor CM, Schulman KA, Curtis LH, Fonarow GC. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol. 2009;53:184–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777–81.

    Article  CAS  PubMed  Google Scholar 

  37. Paulus WJ, van Ballegoij JJ. Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol. 2010;55:526–37.

    Article  PubMed  Google Scholar 

  38. Katz SD, Balidemaj K, Homma S, Wu H, Wang J, Maybaum S. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol. 2000;36:845–51.

    Article  CAS  PubMed  Google Scholar 

  39. Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol. 2004;44:2339–48.

    Article  CAS  PubMed  Google Scholar 

  40. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O’Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E, RELAX Trial. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013;309:1268–77.

    Article  CAS  PubMed  Google Scholar 

  41. Silberman GA, Fan TH, Liu H, Jiao Z, Xiao HD, Lovelock JD, Boulden BM, Widder J, Fredd S, Bernstein KE, Wolska BM, Dikalov S, Harrison DG, Dudley Jr SC. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation. 2010;121:519–28.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Fukuta H, Sane DC, Brucks S, Little WC. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation. 2005;112:357–63.

    Article  CAS  PubMed  Google Scholar 

  43. Xu EZ, Kantores C, Ivanovska J, Engelberts D, Kavanagh BP, McNamara PJ, Jankov RP. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2010;299:H1854–64.

    Article  CAS  PubMed  Google Scholar 

  44. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41:1797–804.

    Article  PubMed  Google Scholar 

  45. Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, Naruke T, Ohsaka T, Nishii M, Takehana H, Izumi T. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J. 2008;72:364–9.

    Article  CAS  PubMed  Google Scholar 

  46. Maekawa E, Inomata T, Watanabe I, Yanagisawa T, Mizutani T, Shinagawa H, Koitabashi T, Takeuchi I, Tokita N, Inoue Y, Izumi T. Prognostic significance of right ventricular dimension on acute decompensation in chronic left-sided heart failure. Int Heart J. 2011;52:119–26.

    Article  PubMed  Google Scholar 

  47. Khush KK, Tasissa G, Butler J, McGlothlin D, De Marco T. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J. 2009;157:1026–34.

    Article  PubMed  Google Scholar 

  48. Aronson D, Eitan A, Dragu R, Burger AJ. Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure. Circ Heart Fail. 2011;4:644–50.

    Article  PubMed  Google Scholar 

  49. Patlolla B, Beygui R, Hadda F. Right-ventricular failure following left ventricle assist device implantation. Curr Opin Cardiol. 2013;28:223–33.

    Article  PubMed  Google Scholar 

  50. Miller LW, Guglin M. Patient selection for ventricular assist devices. A moving target. J Am Coll Cardiol. 2013;61:1209–21.

    Article  PubMed  Google Scholar 

  51. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, Poirier VL, Dasse KA, HeartMate LVAS Investigators. Left Ventricular Assist System. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122:1186–95.

    Article  CAS  PubMed  Google Scholar 

  52. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, Hsu AP, Yeager ML, Buda T, Hoercher KJ, Howard MW, Takagaki M, Doi K, Fukamachi K. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106(12 Suppl 1):I198–202.

    PubMed  Google Scholar 

  53. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, Oz MC, Naka Y. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1–6.

    Article  PubMed  Google Scholar 

  54. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163–72.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ, HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.

    Article  PubMed  Google Scholar 

  56. Holman WL. Interagency registry for mechanically assisted circulatory support (INTERMACS): what have we learned and what will we learn? Circulation. 2012;126:1401–6.

    Article  PubMed  Google Scholar 

  57. Moon MR, Castro LJ, DeAnda A, Tomizawa Y, Daughters 2nd GT, Ingels Jr NB, Miller DC. Right ventricular dynamics during left ventricular assistance in closed-chest dogs. Ann Thorac Surg. 1993;56:54–66.

    Article  CAS  PubMed  Google Scholar 

  58. Caruso R, Campolo C, Milazzo F. Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance. Cytokine. 2012;59:138–44.

    Article  CAS  PubMed  Google Scholar 

  59. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497–505.

    Article  PubMed  Google Scholar 

  60. Fitzpatrick 3rd JR, Frederick JR, Hsu VM, Kozin ED, O’Hara ML, Howell E, Dougherty D, McCormick RC, Laporte CA, Cohen JE, Southerland KW, Howard JL, Jessup ML, Morris RJ, Acker MA, Woo YJ. Risk score derived from preoperative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27:1286–92.

    Article  PubMed Central  PubMed  Google Scholar 

  61. Puwanant S, Hamilton KK, Klodell CT, Hill JA, Schofield RS, Cleeton TS, Pauly DF, Aranda Jr JM. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant. 2008;27:1102–7.

    Article  PubMed  Google Scholar 

  62. Kukucka M, Stepanenko A, Potapov E, Krabatsch T, Redlin M, Mladenow A, Kuppe H, Hetzer R, Habazettl H. Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2011;30:64–9.

    Article  PubMed  Google Scholar 

  63. Grant AD, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012;60:521–8.

    Article  PubMed  Google Scholar 

  64. Potapov EV, Stepanenko A, Dandel M, Kukucka M, Lehmkuhl HB, Weng Y, Hennig F, Krabatsch T, Hetzer R. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant. 2008;27:1275–81.

    Article  PubMed  Google Scholar 

  65. Kato TS, Farr M, Schulze PC. Usefulness of two-dimensional echocardiographic parameters of the left side of the heart to predict right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2012;109:246–51.

    Article  PubMed  Google Scholar 

  66. Deswarte G, Kirsch M, Lesault PF, Trochu JN, Damy T. Right ventricular reserve and outcome after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2010;29:1196–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Cardiologia, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi, 19, Pavia, 27100, Italy

    Stefano Ghio MD, Claudia Raineri MD & Laura Scelsi MD

Authors
  1. Stefano Ghio MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Raineri MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Scelsi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefano Ghio MD .

Editor information

Editors and Affiliations

  1. National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland

    Sean P. Gaine

  2. Department of Cardiology, Erasme University Hospital, Brussels, Belgium

    Robert Naeije

  3. Scottish Pulmonary Vascular Unit, Regional Heart and Lung Centre, Glasgow, United Kingdom

    Andrew John Peacock

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Ghio, S., Raineri, C., Scelsi, L. (2014). Left Heart Failure. In: Gaine, S., Naeije, R., Peacock, A. (eds) The Right Heart. Springer, London. https://doi.org/10.1007/978-1-4471-2398-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2398-9_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2397-2

  • Online ISBN: 978-1-4471-2398-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation